MedPath

Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis

Phase 2
Completed
Conditions
Eosinophilic Esophagitis
Interventions
Drug: Placebo
Registration Number
NCT02098473
Lead Sponsor
Celgene
Brief Summary

The purpose of this study is to determine the effective dose(s) of RPC4046 in the treatment of Eosinophilic Esophagitis (EoE). This trial consists of two phases: 16 weeks of double-blind treatment and 52 weeks of open-label extension.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Histologic evidence of EoE
  • Clinical symptoms of EoE including dysphagia
Exclusion Criteria
  • Primary causes of esophageal eosinophilia other than EoE

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RPC4046 High DoseRPC4046intravenous (IV) infusion only once at first dose, 2 subcutaneous (SC) injections weekly for 16 weeks, high dose
PlaceboPlacebointravenous (IV) infusion only once at first dose, 2 subcutaneous (SC) injections weekly for 16 weeks
RPC4046 Low DoseRPC4046intravenous (IV) infusion only once at first dose, 2 subcutaneous (SC) injections weekly for 16 weeks, low dose
Primary Outcome Measures
NameTimeMethod
Mean Eosinophil CountWeek 16
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (30)

West Michigan Clinical Research Center Gastroenterology Associates of Western Michigan

๐Ÿ‡บ๐Ÿ‡ธ

Wyoming, Michigan, United States

Metropolitan Gastroenterology Group Chevy Chase Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Chevy Chase, Maryland, United States

GI Associates and Endoscopy Center-GI Clinical Research Department

๐Ÿ‡บ๐Ÿ‡ธ

Flowood, Mississippi, United States

Darthmouth Hitchcock Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Lebanon, New Hampshire, United States

Mayo Clinic - Arizona

๐Ÿ‡บ๐Ÿ‡ธ

Scottsdale, Arizona, United States

Alliance Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Oceanside, California, United States

Connecticut Clinical Research Foundation

๐Ÿ‡บ๐Ÿ‡ธ

Bristol, Connecticut, United States

Desert Sun Clinical Research, LLC

๐Ÿ‡บ๐Ÿ‡ธ

Tucson, Arizona, United States

University of Florida

๐Ÿ‡บ๐Ÿ‡ธ

Gainesville, Florida, United States

Borland-Groover Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Jacksonville, Florida, United States

University of Iowa Hospitals and Clinics

๐Ÿ‡บ๐Ÿ‡ธ

Iowa City, Iowa, United States

Minnesota Gastroenterology

๐Ÿ‡บ๐Ÿ‡ธ

Plymouth, Minnesota, United States

Great Lakes Gastroenterology Research

๐Ÿ‡บ๐Ÿ‡ธ

Mentor, Ohio, United States

Gastrointestinal Research Group, University of Calgary Health

๐Ÿ‡จ๐Ÿ‡ฆ

Calgary, Alberta, Canada

Centre Hospitalier Universitaire Vaudois (CHUV)

๐Ÿ‡จ๐Ÿ‡ญ

Lausanne, Switzerland

Swiss EoE Clinic

๐Ÿ‡จ๐Ÿ‡ญ

Olten, Switzerland

Precision Research Institute, LLC

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, California, United States

University of Colorado School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Aurora, Colorado, United States

Children's Center for Digestive Healthcare

๐Ÿ‡บ๐Ÿ‡ธ

Atlanta, Georgia, United States

Grand Teton Research Group

๐Ÿ‡บ๐Ÿ‡ธ

Idaho Falls, Idaho, United States

Northwestern University-Feinberg School of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Indiana University

๐Ÿ‡บ๐Ÿ‡ธ

Indianapolis, Indiana, United States

Southwest Gastroenterology

๐Ÿ‡บ๐Ÿ‡ธ

Oak Lawn, Illinois, United States

Vanderbilt University

๐Ÿ‡บ๐Ÿ‡ธ

Nashville, Tennessee, United States

Gastroenterology and Hepatology Service Walter Reed National Military Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Bethesda, Maryland, United States

Asheville Gastroenterology Associates, PA

๐Ÿ‡บ๐Ÿ‡ธ

Asheville, North Carolina, United States

University of North Carolina

๐Ÿ‡บ๐Ÿ‡ธ

Chapel Hill, North Carolina, United States

Cincinnati Children's Hospital Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Cincinnati, Ohio, United States

University of Pennsylvania Perelman Center for Advanced Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

University of Utah Division of Gastroenterology

๐Ÿ‡บ๐Ÿ‡ธ

Salt Lake City, Utah, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath